Colin Shannon, President & CEO at PRA Health Sciences, Inc. (PRAH), sold 374,651 shares at $168.30 ($62.9M) on 2021-06-15, disclosed to the SEC on 2021-06-17.
Open-market sale of $62.9M PRAH by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $168.30 | 142,093 | $23.9M | 38.0% |
| 2 | $168.30 | 142,093 | $23.9M | 38.0% |
| 3 | $168.75 | 1,210 | $204K | 0.3% |
| 4 | $168.75 | 1,210 | $204K | 0.3% |
| 5 | $166.44 | 83,941 | $14.0M | 22.2% |
| 6 | $167.49 | 4,104 |
| $687K |
| 1.1% |
| Total | $167.88 avg | 374,651 | $62.9M | 100% |
| Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |
| PRAH | SELL | 2017-08-16 | $59.9M | — | Filing → |